Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

Objective: Interferon-free therapy for hepatitis C virus (HCV) infection is costly, and therefore patients with advanced fibrosis are prioritized. Although coupled with considerable side effects, a large proportion of genotype 2/3 infected patients achieve a sustained virological response (SVR) foll...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Scand J Gastroenterol
Asıl Yazarlar: Waldenström, Jesper, Färkkilä, Martti, Rembeck, Karolina, Norkrans, Gunnar, Langeland, Nina, Mørch, Kristine, Pedersen, Court, Rauning Buhl, Mads, Nieminen, Urpo, Nuutinen, Hannu, Alsiö, Åsa, Holmström, Lars, Jungnelius, Rolf, Lund, Katarina, Rubensson, Anders, Torell, Erik, Westin, Johan, Lagging, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Informa Healthcare 2016
Konular:
Liver and Biliary Tract
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732462/
https://ncbi.nlm.nih.gov/pubmed/26418670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00365521.2015.1087588
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller